Literature DB >> 31535650

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's disease.

Leonardo Brunetti1, Antonio Laghezza1, Fulvio Loiodice1, Paolo Tortorella1, Luca Piemontese1.   

Abstract

Entities:  

Year:  2020        PMID： 31535650     DOI： 10.4103/1673-5374.264458

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN： 1673-5374            Impact factor:   5.135


× No keyword cloud information.
  4 in total

1.  Can foods influence the onset and progress of neurodegenerative diseases?

Authors:  Luca Piemontese; Leonardo Brunetti; Rosalba Leuci
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

2.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.

Authors:  Mona Khorani; Gerd Bobe; Donald G Matthews; Armando Alcazar Magana; Maya Caruso; Nora E Gray; Joseph F Quinn; Jan F Stevens; Amala Soumyanath; Claudia S Maier
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Authors:  Rosalba Leuci; Leonardo Brunetti; Antonio Laghezza; Luca Piemontese; Antonio Carrieri; Leonardo Pisani; Paolo Tortorella; Marco Catto; Fulvio Loiodice
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

4.  Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.

Authors:  Leonardo Brunetti; Antonio Carrieri; Luca Piemontese; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.